Spiruchostatin
Spiruchostatin
Spiruchostatin (pronunciation: /spi·ru·cho·stat·in/) is a biological compound known for its potential in cancer treatment.
Etymology
The term "Spiruchostatin" is derived from the name of the bacteria Spirulina, from which it was first isolated, and the suffix "-statin", which is commonly used in the names of drugs that inhibit or reduce a certain activity.
Definition
Spiruchostatin is a histone deacetylase inhibitor (HDAC inhibitor), a class of compounds that interfere with the function of histone deacetylase. HDACs are enzymes that remove acetyl groups from an ε-N-acetyl lysine amino acid on a histone, allowing the histones to wrap the DNA more tightly. This function is crucial to the regulation of gene expression.
Usage
Spiruchostatin, like other HDAC inhibitors, has been studied for its potential use in cancer treatment. By inhibiting the function of HDACs, these compounds can potentially stop the growth of cancer cells and induce apoptosis, or programmed cell death.
Related Terms
External links
- Medical encyclopedia article on Spiruchostatin
- Wikipedia's article - Spiruchostatin
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski